ATE131733T1 - Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese - Google Patents
Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophoreseInfo
- Publication number
- ATE131733T1 ATE131733T1 AT91908337T AT91908337T ATE131733T1 AT E131733 T1 ATE131733 T1 AT E131733T1 AT 91908337 T AT91908337 T AT 91908337T AT 91908337 T AT91908337 T AT 91908337T AT E131733 T1 ATE131733 T1 AT E131733T1
- Authority
- AT
- Austria
- Prior art keywords
- fatty acids
- iontophoresis
- medication
- administration
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Electrotherapy Devices (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51050290A | 1990-04-18 | 1990-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE131733T1 true ATE131733T1 (de) | 1996-01-15 |
Family
ID=24031010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91908337T ATE131733T1 (de) | 1990-04-18 | 1991-04-15 | Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0525063B1 (de) |
JP (1) | JP3261501B2 (de) |
AT (1) | ATE131733T1 (de) |
AU (1) | AU650879B2 (de) |
CA (1) | CA2078998A1 (de) |
DE (1) | DE69115687T2 (de) |
DK (1) | DK0525063T3 (de) |
ES (1) | ES2081476T3 (de) |
FI (1) | FI924724A0 (de) |
GR (1) | GR3018883T3 (de) |
IE (1) | IE73245B1 (de) |
NO (1) | NO924029D0 (de) |
NZ (1) | NZ237489A (de) |
PT (1) | PT97410B (de) |
WO (1) | WO1991016077A1 (de) |
ZA (1) | ZA912192B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002232A1 (en) * | 1994-07-13 | 1996-02-01 | Alza Corporation | Composition and method for enhancing transdermal electrotransport agent delivery |
US5990179A (en) * | 1995-04-28 | 1999-11-23 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US5985316A (en) * | 1995-04-28 | 1999-11-16 | Alza Corporation | Composition and method of enhancing electrotransport agent delivery |
US6757560B1 (en) | 1999-04-09 | 2004-06-29 | Novosis Pharma Ag | Transdermal delivery system (TDS) with electrode network |
DE19816143A1 (de) | 1998-04-09 | 1999-10-21 | Fischer Wilfried | Transdermales Applikationssystem (TDS) mit Elektrodenraster |
EP1457233B1 (de) | 2003-03-12 | 2007-07-11 | Novosis AG | Transdermales Wirkstoffverabreichungssystem mit Elektrodenraster |
DE102007020799A1 (de) | 2007-05-03 | 2008-11-06 | Novosis Ag | Transdermales therapeutisches System mit Remifentanil |
DE102007021549A1 (de) | 2007-05-08 | 2008-11-13 | Novosis Ag | Transdermales therapeutisches System enthaltend mindestens zwei Opioide |
DE102007058504A1 (de) | 2007-12-05 | 2009-07-09 | Acino Ag | Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR) |
DE102010024558B4 (de) | 2010-06-22 | 2016-04-21 | Amw Gmbh | Transdermales therapeutisches System mit Elektroden |
CN115436538B (zh) * | 2022-09-17 | 2023-08-01 | 山东省计量科学研究院 | 一种肉类食品基体兽药残留标准物质制备装置与方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
EP0375689B1 (de) * | 1987-06-01 | 1992-08-12 | Warner-Lambert Company | Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids. |
EP0351897A3 (de) * | 1988-06-17 | 1990-03-21 | The Procter & Gamble Company | Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze |
-
1991
- 1991-03-19 NZ NZ237489A patent/NZ237489A/en unknown
- 1991-03-22 ZA ZA912192A patent/ZA912192B/xx unknown
- 1991-04-15 AT AT91908337T patent/ATE131733T1/de not_active IP Right Cessation
- 1991-04-15 JP JP50804791A patent/JP3261501B2/ja not_active Expired - Lifetime
- 1991-04-15 EP EP91908337A patent/EP0525063B1/de not_active Expired - Lifetime
- 1991-04-15 CA CA002078998A patent/CA2078998A1/en not_active Abandoned
- 1991-04-15 WO PCT/US1991/002569 patent/WO1991016077A1/en active IP Right Grant
- 1991-04-15 DK DK91908337.8T patent/DK0525063T3/da active
- 1991-04-15 AU AU77500/91A patent/AU650879B2/en not_active Expired
- 1991-04-15 DE DE69115687T patent/DE69115687T2/de not_active Expired - Lifetime
- 1991-04-15 ES ES91908337T patent/ES2081476T3/es not_active Expired - Lifetime
- 1991-04-17 IE IE128091A patent/IE73245B1/en not_active IP Right Cessation
- 1991-04-18 PT PT97410A patent/PT97410B/pt not_active IP Right Cessation
-
1992
- 1992-10-16 NO NO924029A patent/NO924029D0/no unknown
- 1992-10-19 FI FI924724A patent/FI924724A0/fi not_active Application Discontinuation
-
1996
- 1996-02-01 GR GR960400277T patent/GR3018883T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI924724A (fi) | 1992-10-19 |
DE69115687T2 (de) | 1996-07-18 |
AU7750091A (en) | 1991-11-11 |
EP0525063A1 (de) | 1993-02-03 |
GR3018883T3 (en) | 1996-05-31 |
FI924724A0 (fi) | 1992-10-19 |
JP3261501B2 (ja) | 2002-03-04 |
EP0525063B1 (de) | 1995-12-20 |
AU650879B2 (en) | 1994-07-07 |
ES2081476T3 (es) | 1996-03-16 |
ZA912192B (en) | 1992-01-29 |
JPH05506232A (ja) | 1993-09-16 |
IE911280A1 (en) | 1991-10-23 |
DK0525063T3 (da) | 1996-01-29 |
PT97410A (pt) | 1992-01-31 |
NZ237489A (en) | 1995-07-26 |
CA2078998A1 (en) | 1991-10-19 |
IE73245B1 (en) | 1997-05-21 |
NO924029L (no) | 1992-10-16 |
WO1991016077A1 (en) | 1991-10-31 |
DE69115687D1 (de) | 1996-02-01 |
PT97410B (pt) | 1998-08-31 |
NO924029D0 (no) | 1992-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8404243L (sv) | Forfarande och anordning for elektro-terapeutisk behandling | |
SE8703625D0 (sv) | New medical use | |
ATE122899T1 (de) | Verfahren und gegenstand zur transdermalen administration von dexmedetomidin. | |
ES2000428T3 (es) | Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente. | |
ES550011A0 (es) | Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol | |
DE3856306D1 (de) | Verfahren zur Herstellung von Applikatoren zur transdermalen Verabreichung von Medikamenten | |
DE3585618D1 (de) | Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns. | |
ATE131733T1 (de) | Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese | |
EP0299756A3 (en) | Anti-acne composition | |
ATE18353T1 (de) | Verfahren zur herstellung von liposomenloesungen. | |
DE3667610D1 (de) | System zur verabreichung von substanzen durch die haut. | |
ATA160487A (de) | Verfahren zur herstellung eines transdermalen therapeutischen membransystems mit diclofenac | |
FI95653C (fi) | Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi | |
DE68924714D1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
DE68904462D1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten. | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
DE58908604D1 (de) | Medizinisches Gerät zur Stimulation eines physiologischen Vorganges eines Lebewesens mit sich selbsttätig an die körperliche Aktivität des Lebewesens anpassender Stimulationsintensiät. | |
ES8201535A1 (es) | Un procedimiento para la preparacion de nuevos acil-deriva- dos de carnitina | |
ES2081279T3 (es) | Utilizacion de 15-desoxiespergualina como medicamento. | |
DE3280277D1 (de) | Verfahren zur herstellung eines spezifisch auf das ernaehrungszentrum wirkenden appetitregelnden wirkstoffes sowie der nach diesem verfahren erhaeltliche wirkstoff. | |
DE3574675D1 (de) | Verfahren zum sterilisieren von rekombinantem mikroorganismus. | |
ATE28384T1 (de) | Medizinisches verfahren und zubereitung. | |
AT386121B (de) | Verfahren zur herstellung eines pharmazeutischen praeparates | |
ATA386679A (de) | Verfahren zum herstellen von 3-pyrrolin-2-onen bzw. von pyrrolidin-2-onen, von optisch aktiven isomeren und cis- bzw. trans-isomeren hievon | |
ATE58831T1 (de) | Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |